BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 31319863)

  • 1. Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activation.
    Ciardiello C; Leone A; Lanuti P; Roca MS; Moccia T; Minciacchi VR; Minopoli M; Gigantino V; De Cecio R; Rippa M; Petti L; Capone F; Vitagliano C; Milone MR; Pucci B; Lombardi R; Iannelli F; Di Gennaro E; Bruzzese F; Marchisio M; Carriero MV; Di Vizio D; Budillon A
    J Exp Clin Cancer Res; 2019 Jul; 38(1):317. PubMed ID: 31319863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic analysis of zoledronic-acid resistant prostate cancer cells unveils novel pathways characterizing an invasive phenotype.
    Milone MR; Pucci B; Bifulco K; Iannelli F; Lombardi R; Ciardiello C; Bruzzese F; Carriero MV; Budillon A
    Oncotarget; 2015 Mar; 6(7):5324-41. PubMed ID: 25481874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrin αv expression is required for the acquisition of a metastatic stem/progenitor cell phenotype in human prostate cancer.
    van den Hoogen C; van der Horst G; Cheung H; Buijs JT; Pelger RC; van der Pluijm G
    Am J Pathol; 2011 Nov; 179(5):2559-68. PubMed ID: 21907176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large oncosomes contain distinct protein cargo and represent a separate functional class of tumor-derived extracellular vesicles.
    Minciacchi VR; You S; Spinelli C; Morley S; Zandian M; Aspuria PJ; Cavallini L; Ciardiello C; Reis Sobreiro M; Morello M; Kharmate G; Jang SC; Kim DK; Hosseini-Beheshti E; Tomlinson Guns E; Gleave M; Gho YS; Mathivanan S; Yang W; Freeman MR; Di Vizio D
    Oncotarget; 2015 May; 6(13):11327-41. PubMed ID: 25857301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Annexin A1 is involved in the acquisition and maintenance of a stem cell-like/aggressive phenotype in prostate cancer cells with acquired resistance to zoledronic acid.
    Bizzarro V; Belvedere R; Milone MR; Pucci B; Lombardi R; Bruzzese F; Popolo A; Parente L; Budillon A; Petrella A
    Oncotarget; 2015 Sep; 6(28):25076-92. PubMed ID: 26312765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models.
    Li Y; Drabsch Y; Pujuguet P; Ren J; van Laar T; Zhang L; van Dam H; Clément-Lacroix P; Ten Dijke P
    Breast Cancer Res; 2015 Feb; 17(1):28. PubMed ID: 25849225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells.
    Milone MR; Pucci B; Bruzzese F; Carbone C; Piro G; Costantini S; Capone F; Leone A; Di Gennaro E; Caraglia M; Budillon A
    Cell Death Dis; 2013 May; 4(5):e641. PubMed ID: 23703386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of α(v)-integrins in stem/progenitor cells and supportive microenvironment impairs bone metastasis in human prostate cancer.
    van der Horst G; van den Hoogen C; Buijs JT; Cheung H; Bloys H; Pelger RC; Lorenzon G; Heckmann B; Feyen J; Pujuguet P; Blanque R; Clément-Lacroix P; van der Pluijm G
    Neoplasia; 2011 Jun; 13(6):516-25. PubMed ID: 21677875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYC Mediates Large Oncosome-Induced Fibroblast Reprogramming in Prostate Cancer.
    Minciacchi VR; Spinelli C; Reis-Sobreiro M; Cavallini L; You S; Zandian M; Li X; Mishra R; Chiarugi P; Adam RM; Posadas EM; Viglietto G; Freeman MR; Cocucci E; Bhowmick NA; Di Vizio D
    Cancer Res; 2017 May; 77(9):2306-2317. PubMed ID: 28202510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo effects of short hairpin RNA targeting integrin-linked kinase in prostate cancer cells.
    Yuan Y; Xiao Y; Li Q; Liu Z; Zhang X; Qin C; Xie J; Wang X; Xu T
    Mol Med Rep; 2013 Aug; 8(2):419-24. PubMed ID: 23783575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET imaging with [⁶⁸Ga]NOTA-RGD for prostate cancer: a comparative study with [¹⁸F]fluorodeoxyglucose and [¹⁸F]fluoroethylcholine.
    Israel I; Richter D; Stritzker J; van Ooschot M; Donat U; Buck AK; Samnick S
    Curr Cancer Drug Targets; 2014; 14(4):371-9. PubMed ID: 24720338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sin1 promotes proliferation and invasion of prostate cancer cells by modulating mTORC2-AKT and AR signaling cascades.
    Huang Y; Feng G; Cai J; Peng Q; Yang Z; Yan C; Yang L; Wang Z
    Life Sci; 2020 May; 248():117449. PubMed ID: 32088212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
    Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
    Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer.
    Sequeiros T; Rigau M; Chiva C; Montes M; Garcia-Grau I; Garcia M; Diaz S; Celma A; Bijnsdorp I; Campos A; Di Mauro P; Borrós S; Reventós J; Doll A; Paciucci R; Pegtel M; de Torres I; Sabidó E; Morote J; Olivan M
    Oncotarget; 2017 Jan; 8(3):4960-4976. PubMed ID: 27903962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of alpha-v integrins reduces malignancy of bladder carcinoma.
    van der Horst G; Bos L; van der Mark M; Cheung H; Heckmann B; Clément-Lacroix P; Lorenzon G; Pelger RC; Bevers RF; van der Pluijm G
    PLoS One; 2014; 9(9):e108464. PubMed ID: 25247809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. αv integrin: a new gastrin target in human pancreatic cancer cells.
    Cayrol C; Bertrand C; Kowalski-Chauvel A; Daulhac L; Cohen-Jonathan-Moyal E; Ferrand A; Seva C
    World J Gastroenterol; 2011 Oct; 17(40):4488-95. PubMed ID: 22110279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrin alpha 6 expression in human prostate carcinoma cells is associated with a migratory and invasive phenotype in vitro and in vivo.
    Rabinovitz I; Nagle RB; Cress AE
    Clin Exp Metastasis; 1995 Nov; 13(6):481-91. PubMed ID: 7586806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell Stress Induced Stressome Release Including Damaged Membrane Vesicles and Extracellular HSP90 by Prostate Cancer Cells.
    Eguchi T; Sogawa C; Ono K; Matsumoto M; Tran MT; Okusha Y; Lang BJ; Okamoto K; Calderwood SK
    Cells; 2020 Mar; 9(3):. PubMed ID: 32204513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting ECM-integrin interaction with liposome-encapsulated small interfering RNAs inhibits the growth of human prostate cancer in a bone xenograft imaging model.
    Bisanz K; Yu J; Edlund M; Spohn B; Hung MC; Chung LW; Hsieh CL
    Mol Ther; 2005 Oct; 12(4):634-43. PubMed ID: 16039164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene Editing of α6 Integrin Inhibits Muscle Invasive Networks and Increases Cell-Cell Biophysical Properties in Prostate Cancer.
    Rubenstein CS; Gard JMC; Wang M; McGrath JE; Ingabire N; Hinton JP; Marr KD; Simpson SJ; Nagle RB; Miranti CK; Warfel NA; Garcia JGN; Arif-Tiwari H; Cress AE
    Cancer Res; 2019 Sep; 79(18):4703-4714. PubMed ID: 31337652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.